Paydirt
ATTO
Ticker

Attovia Therapeutics, Inc. Common Stock

ATTO

Attovia Therapeutics, Inc. Common Stock (ATTO) has 8 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 8 purchases and 4 sales, 8 filed past the deadline. Filers took a median of 8 days from execution to disclosure, and the most recent trade was executed Aug 6 and filed Aug 28. The most active filer was Goldman Sachs Group Inc with 2 filings.

Add to watchlist
Filings, ttm
8
8 buys · 4 sells · 8 late
Traders, ttm
6
6 insiders
Volume, ttmiDollar value disclosed in the window
$80.6M
estimated for Congress, as filed for insiders
Median delay
8d
execution to disclosure
Last traded
Aug 6
Filed Aug 28
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$25.55 (+16.7%)
$25.55$21.80$18.06Aug 5Aug 20Sep 4

Adjusted for splits and dividends.

Volume by month
$72.9M$36.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Aug 2026 · buys $72.9MAug 2026 · sells $7.6M
Buys $72.9M Sells $7.6M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
GI Goldman Sachs Group Inc Other 2 filings CW Colin Walsh Director 2 filings FP Frazier Life Sciences XI, L.P. 10% owner 1 filing RL Redmile Group, LLC 10% owner 1 filing S Sanofi 10% owner 1 filing VP venBio Global Strategic Fund IV, L.P. 10% owner 1 filing
Recent filings
Colin WalshPURCHASE Director $10.3M
585,000 sh across 2 lots
Exec Aug 5
Filed Aug 28 · 5:38 PM ET † Colin WalshSALE Director $1.9M
90,151 sh across 3 lots
Exec Aug 5
Filed Aug 28 · 5:38 PM ET † Goldman Sachs Group IncPURCHASE Other $10.3M
585,000 sh across 2 lots
Exec Aug 5
Filed Aug 28 · 5:38 PM ET † Goldman Sachs Group IncSALE Other $1.9M
90,151 sh across 3 lots
Exec Aug 5
Filed Aug 28 · 5:38 PM ET † Colin WalshSALE Director $1.9M
90,151 sh across 3 lots
Exec Aug 5
Filed Aug 13 · 9:52 PM ET † Colin WalshPURCHASE Director $10.3M
585,000 sh across 2 lots
Exec Aug 5
Filed Aug 13 · 9:52 PM ET † Goldman Sachs Group IncSALE Other $1.9M
90,151 sh across 3 lots
Exec Aug 5
Filed Aug 13 · 9:51 PM ET † Goldman Sachs Group IncPURCHASE Other $10.3M
585,000 sh across 2 lots
Exec Aug 5
Filed Aug 13 · 9:51 PM ET † venBio Global Strategic Fund IV, L.P.PURCHASE 10% owner $6.5M
382,352 sh × $17.00
Exec Aug 6
Filed Aug 10 · 4:12 PM ET Redmile Group, LLCPURCHASE 10% owner $10.2M
600,000 sh across 2 lots
Exec Aug 6
Filed Aug 7 · 9:47 PM ET SanofiPURCHASE 10% owner $5.1M
300,000 sh × $17.00
Exec Aug 6
Filed Aug 7 · 3:45 PM ET Frazier Life Sciences XI, L.P.PURCHASE 10% owner $10.0M
588,235 sh × $17.00
Exec Aug 6
Filed Aug 6 · 5:35 PM ET